Chapter 39: Problem 9
Memantine is approved for use in which disease? a. moderate to severe Huntington disease b. early stages of Huntington disease c. moderate to severe Alzheimer disease d. early stages of Alzheimer disease
Chapter 39: Problem 9
Memantine is approved for use in which disease? a. moderate to severe Huntington disease b. early stages of Huntington disease c. moderate to severe Alzheimer disease d. early stages of Alzheimer disease
All the tools & learning materials you need for study success - in one app.
Get started for freeProposed mechanisms in neurodegenerative diseases include all of the following EXCEPT: a. oxidative stress b. apoptosis c. inflammation d. excess GABA
Which medication is currently FDA approved for the treatment of pseudobulbar affect in ALS? a. dextromethorphan/quinidine b. SSRI antidepressants c. tricyclic antidepressants d. none of the above
In ALS patients, sialorrhea can be a major symptom as bulbar weakness worsens. Which of these medications is ideal for a patient with swallowing difficulty? a. amitriptyline b. scopolamine c. diphenyhydramine d. glycopyrrolate
Major side effects of levodopa therapy include which of the following? a. nausea, vomiting, anorexia and orthostatic hypotension b. abnormal liver function tests c. bradykinesia and tremor d. dry eyes and dry mouth
Amantadine is a useful medication in the treatment of dyskinesias in Parkinson Disease. What side effect limits its use in the elderly? a. diarrhea b. sialorrhea c. dyskinesias d. neuropsychiatric and cognitive effects
What do you think about this solution?
We value your feedback to improve our textbook solutions.